Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Campbell

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Purinergic Signalling|August 24, 2022
Inhibition of P2X7 receptors by Lu AF27139 diminishes colonic hypersensitivity and CNS prostanoid levels in a rat model of visceral painRoland G W Staal, Adarsh Gandhi, Hua Zhou, et al.
Bioorganic & Medicinal Chemistry Letters|September 19, 2008
Identification and SAR around N-{2-[4-(2,3-dihydro-benzo[1,4]dioxin-2-ylmethyl)-[1,4]diazepan-1-yl]-ethyl}-2-phenoxy-nicotinamide, a selective alpha2C adrenergic receptor antagonistSnahel D Patel, Wendy M Habeski, Hyunsuk Min, et al.
Heart (British Cardiac Society)|June 1, 2013
Can we improve the detection of heart valve disease?Chris Arden, John B Chambers, Jonathan Sandoe, et al.
Heart (British Cardiac Society)|September 2, 2020
Outpatient management of heart valve disease following the COVID-19 pandemic: implications for present and future careBenoy Nalin Shah, Dominik Schlosshan, Hannah Zelie Ruth McConkey, et al.
Glia|June 2, 2016
Critical data-based re-evaluation of minocycline as a putative specific microglia inhibitorThomas Möller, Frédérique Bard, Anindya Bhattacharya, et al.
Journal of Clinical Microbiology|December 8, 2005
Polyphasic characterization reveals that the human pathogen Mycobacterium peregrinum type II belongs to the bovine pathogen species Mycobacterium senegalenseRichard J Wallace, Barbara A Brown-Elliott, June Brown, et al.
Bioorganic & Medicinal Chemistry Letters|March 13, 2017
Discovery of orally active hepatoselective glucokinase activators for treatment of Type II Diabetes MellitusJiayi Xu, Songnian Lin, Robert W Myers, et al.
Bioorganic & Medicinal Chemistry Letters|March 13, 2017
Novel, highly potent systemic glucokinase activators for the treatment of Type 2 Diabetes MellitusJiayi Xu, Songnian Lin, Robert W Myers, et al.
Annals of the New York Academy of Sciences|October 29, 2011
Advancing drug discovery for schizophreniaStephen R Marder, Bryan Roth, Patrick F Sullivan, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Purinergic Signalling|August 24, 2022
Inhibition of P2X7 receptors by Lu AF27139 diminishes colonic hypersensitivity and CNS prostanoid levels in a rat model of visceral painRoland G W Staal, Adarsh Gandhi, Hua Zhou, et al.
Bioorganic & Medicinal Chemistry Letters|September 19, 2008
Identification and SAR around N-{2-[4-(2,3-dihydro-benzo[1,4]dioxin-2-ylmethyl)-[1,4]diazepan-1-yl]-ethyl}-2-phenoxy-nicotinamide, a selective alpha2C adrenergic receptor antagonistSnahel D Patel, Wendy M Habeski, Hyunsuk Min, et al.
Heart (British Cardiac Society)|June 1, 2013
Can we improve the detection of heart valve disease?Chris Arden, John B Chambers, Jonathan Sandoe, et al.
Heart (British Cardiac Society)|September 2, 2020
Outpatient management of heart valve disease following the COVID-19 pandemic: implications for present and future careBenoy Nalin Shah, Dominik Schlosshan, Hannah Zelie Ruth McConkey, et al.
Glia|June 2, 2016
Critical data-based re-evaluation of minocycline as a putative specific microglia inhibitorThomas Möller, Frédérique Bard, Anindya Bhattacharya, et al.
Journal of Clinical Microbiology|December 8, 2005
Polyphasic characterization reveals that the human pathogen Mycobacterium peregrinum type II belongs to the bovine pathogen species Mycobacterium senegalenseRichard J Wallace, Barbara A Brown-Elliott, June Brown, et al.
Bioorganic & Medicinal Chemistry Letters|March 13, 2017
Discovery of orally active hepatoselective glucokinase activators for treatment of Type II Diabetes MellitusJiayi Xu, Songnian Lin, Robert W Myers, et al.
Bioorganic & Medicinal Chemistry Letters|March 13, 2017
Novel, highly potent systemic glucokinase activators for the treatment of Type 2 Diabetes MellitusJiayi Xu, Songnian Lin, Robert W Myers, et al.
Annals of the New York Academy of Sciences|October 29, 2011
Advancing drug discovery for schizophreniaStephen R Marder, Bryan Roth, Patrick F Sullivan, et al.
Pageof 4